Date RFP Issued: January 15, 2021
Geographic Scope: all countries except the United States
Clinical Area: Transthyretin Amyloid Polyneuropathy (ATTR-PN)
Link to full RFP: Junior Investigator Transthyretin Amyloid Polyneuropathy (ATTR-PN) Research
Application Due Date: March 22, 2021
Specific Area of Interest: Pfizer is interested in supporting research proposals that advance our understanding of the epidemiology, basic science and early diagnosis and treatment of ATTR-PN through research focused in the following areas:
- Epidemiologic evaluations for ATTR-PN
- Approaches for the early appropriate diagnosis of ATTR-PN patients
- Evaluation of patients with ATTR-PN presenting with a mixed phenotype
- Real world efficacy and safety of tafamidis monotherapy in the clinical setting for the management of ATTR-PN
- Mechanistic studies to advance the basic science of amyloid formation and deposition